Responsible Development of New Technologies Critical in Complex, Connected World
By Andrew Maynard,
The Conversation
| 03. 04. 2015
Untitled Document
On July 31, 2012, a massive blackout swept across northeast India. At 1 pm local time, a power line in the state of Madhya Pradesh became overloaded and tripped out. As the supply grid struggled to pick up the slack, other lines went down. By 1:03, a cascading series of failures had pushed the electricity supply grid into a state of chaos, resulting in the largest blackout in human history. More than an estimated 600 million people lost power temporarily as a result of the collapse.
This blackout is a stark reminder of how vulnerable we all are to chaotic collapse around the many complex technological systems we rely on. Yet we continue to develop powerful new technologies at a rapid rate, with little thought as to how their very complexity and interconnectedness may cause them to unravel in the future.
The sheer audacity of our technological prowess is reflected in this year’s list of Top Ten Emerging Technologies from the World Economic Forum (WEF) – now in its fourth year. The list spans advances in genetic...
Related Articles
By Alondra Nelson, Science | 01.15.2026
One of the most interventionist approaches to technology governance in the United States in a generation has cloaked itself in the language of deregulation. In early December 2025, President Donald Trump took to Truth Social to announce a forthcoming “One...
By Daphne O. Martschenko and Julia E. H. Brown, Hastings Bioethics Forum | 01.14.2026
There is growing concern that falling fertility rates will lead to economic and demographic catastrophe. The social and political movement known as pronatalism looks to combat depopulation by encouraging people to have as many children as possible. But not just...
By Danny Finley, Bill of Health | 01.08.2026
The United States Food and Drug Administration (FDA) has a unique funding structure among federal scientific and health agencies. The industries it regulates fund nearly half of its budget. The agency charges companies a user fee for each application
...
By George Janes, BioNews | 01.12.2026
A heart attack patient has become the first person to be treated in a clinical trial of an experimental gene therapy, which aims to strengthen blood vessels after coronary bypass surgery.
Coronary artery bypass surgery is performed to treat...